[Discussion] we are measuring amylin at the wrong time and calling it noise
we are measuring amylin at the wrong time and calling it noise. Making the case below, and I expect to lose some of it in the comments.
Bought small deliberately because the evidence base is thin. That felt like the only defensible approach.
Asked a question here that turned out to be based on a mechanism confusion. Three people untangled it patiently.
Kept a log purely because so few people are logging this one. It is one person and it is not data.
Screenshot none of this. Read the whole thread, including the parts where I am told I am wrong.
best — the order this archive was captured in
Nothing containing this compound is approved as a standalone product, and research-use-only material is not approved for human use.
Sent a vial to VendorInvestigate because there was almost nothing on file for this compound. 97.6% against a claimed 97.0%, and I posted it because the log needs entries.
Independent result added to the log. Thank you for paying for it — there are very few on this compound.
the interesting data is the combination, not the monotherapy
Push back: the evidence base here is thin enough that a confident ranking against the established compounds is not supportable.